$QQQ: DAILY 1 YEAR VOLATILITY CHART into #Gilead says NIAID study of remdesivir as COVID-19 treatment met primary endpoint #COVID19 $MRK $AMGN $BMY $AGN $NVS $BIIB $REGN $USO $UCO $RUT $IWM $TGT $LQD https://t.co/fz2RQjU1UK